RESEARCH HIGHLIGHT 31 March 2026 In the phase 3 EVOKE(+) trials, semaglutide did not slow clinical …
Biomarkers
-
-
Ensuring vaccines are effective, accepted Immunologist Erica Andersen-Nissen, PhD, a principal staff scientist in the McElrath Lab, heads …
-
Wu, Z., Zhang, W., Qu, J. & Liu, G. H. Emerging epigenetic insights into aging mechanisms …
-
IMAGINE A DAY when all of your biometrics are measured on a daily continuous monitor, when …
-
Participant disposition Table of Contents Participant disposition Primary outcomes Secondary outcomes Part B cohort with infantile-onset …
-
Translational research has a crucial role in healthcare by applying laboratory-based discoveries to practical patient-focused solutions. …
-
RESEARCH HIGHLIGHT 14 November 2025 Adjuvant atezolizumab improved survival outcomes in patients with muscle-invasive bladder cancer …
-
Nature Medicine, Published online: 26 September 2025; Two: 10.1038/S41591-025-03952-9 Despite mixed efficacy outcomes, a phase 1/2 …
-
Okay, here’s the extracted and formatted list of references from the provided text: 34. Guertin, K. …
-
Nature Medicine, Published online: 10 September 2025; Two: 10.1038/S41591-025-03960-9 Reply to: Critical evaluation of the ProfiLER-02 …
- 1
- 2
